Wednesday, July 19, 2017 (HealthDay News)-New cancer Drug It usually costs more than $ 100,000 a year. cancer The price of medicine is also rising.Now, the American Society of Clinical Studies Oncology (ASCO) offers several suggestions for relieving the patient’s financial distress.
Proposals include allowing Medicare to negotiate drug prices, legalizing drug imports, and adopting bundled or group payment programs.
The new policy statement also states that ASCO will support the creation of a health care “stakeholder” panel to determine the validity of the proposal. Such groups may also outline a unified approach to assessing the value of a drug.
“Undoubtedly, one of the most difficult times in life is cancer You should focus on getting the best possible care, without worrying about the financial burden on your family. ” cancer-Care specialist.
“As cancer doctors, we have a responsibility to ensure that patients receive the right medication at the right time, but that alone cannot keep costs down. To address the main factors that cost patients. Needs US leaders, including rising prices. “
Any solution needs to maintain access to patient care and promote innovation, the policy statement said.
Cancer patients are more than twice as likely to declare bankruptcy as non-cancer patients, and nearly 6 in 10 cancer patients suffer from financial difficulties during treatment. As a result, many patients have abandoned or postponed treatment, the paper said.
Also, Cancer treatment According to ASCO, costs are expected to rise by more than 25% between 2010 and 2020, with drugs being the driving force.
“Drug pricing is clearly too complex and political to tackle without evidence-based solutions,” Hudis said. “We are focused on finding out what works and what the potential downsides and unintended consequences of each intervention are.”
In many cases, the price of a new drug has nothing to do with its effectiveness, the paper said. Society recommends that the US Food and Drug Administration use “meaningful clinical outcomes” when assessing drug applications.
“Ultimately, ASCO believes that there should be a real and consistent relationship between the benefits of a particular drug to the patient and its cost,” the author writes.
The ultimate goal of the proposal is “to develop an approach that protects patients from rising costs while improving care,” Hudis said.
Copyright © 2017 Health Day. all rights reserved.
Source: American Society of Clinical Oncology, News Release, July 19, 2017
A group of doctors provide ideas for reducing the cost of cancer
Source link A group of doctors provide ideas for reducing the cost of cancer